High-Dose Chemotherapy With Autologous PDSCT as Post-Remission Therapy for AML

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1702786
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search